Senator Elizabeth Warren (D-MA) asks
@RushDoshi, director of
@CFR_China, about leveraging federal procurement power to make the U.S. pharmaceutical supply chain less dependent on China.
“The U.S. government has incredible purchasing power, but right now we effectively focus on low cost, not resilience, and not quality. And so as a result, purchasing groups are not incentivized to purchase, you know, with any knowledge of upstream KSM or API dependency.”